Curtis Lockshin Insider Trading $PHIO Phio Pharmaceuticals Corp.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Curtis Lockshin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Curtis Lockshin. Curtis Lockshin is Director in Sorrento Therapeutics, Inc. ($SRNE) and Chief Sciencific Officer in Xenetic Biosciences, Inc. ($XBIO) and Chief Scientific Officer in Xenetic Biosciences, Inc. ($XBIO) and Director in RXi Pharmaceuticals Corp ($RXII).
Curtis Lockshin in Phio Pharmaceuticals Corp.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Curtis Lockshin: Director
Holdings: 10,366 shares
Current Value: $6,634
Latest Transaction: Mar 03 2021
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Curtis Lockshin in Phio Pharmaceuticals Corp.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PHIO, SRNE, XBIO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | PHIO | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,366 | 366 to 10.4 K (+2,732.24 %) |
| Feb 15 2019 | RXII | Phio Pharmaceutica ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 20,130 | 10.1 K to 20.1 K (+98.72 %) |
| Aug 03 2018 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Grant | A | 0.00 | 10,000 | 0 | 10,130 | 130 to 10.1 K (+7,692.31 %) |
| Feb 03 2017 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.63 | 2,000 | 1,258 | 2,000 | |
| Feb 12 2016 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.29 | 16,666 | 4,763 | 16,666 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.52 | 6,000 | 3,120 | 6,000 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.46 | 6,000 | 2,730 | 6,000 | |
| Jun 03 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Grant | A | 0.40 | 12,000 | 4,800 | 13,000 | 1,000 to 13 K (+1,200.00 %) |
| Jun 02 2015 | RXII | RXi Pharmaceutical ... | Lockshin Curtis | Director | Option Exercise | A | 0.38 | 16,666 | 6,333 | 16,666 |
Page: 1